The serine/threonine kinase LKB1 is a tumour suppressor that regulates cell growth, polarity, and proliferation in many different cell types. We previously demonstrated that LKB1 controls thymocyte survival via regulation of AMPK activation. In this study, we show that LKB1 was also involved in thymocyte positive selection through regulation of T cell receptor (TCR) signalling. Both LckCre-and CD4-Cre-mediated deletion of LKB1 impaired the generation of mature CD4 and CD8 single positive (SP) thymocytes that might have resulted from the attenuated tyrosine phosphorylation of phospholipase C-c 1 (PLCc1) in the absence of LKB1. We found that LKB1 was directly phosphorylated by Lck at tyrosine residues 36, 261, and 365 and predominately interacted with LAT and PLCc1 following TCR stimulation. Loss of LKB1 led to impaired recruitment of PLCc1 to the LAT signalosome. Correlatively, LKB1-deficient thymocytes failed to upregulate lineage-specifying factors, and to differentiate into SP thymocytes even if their impaired survival was rescued. These observations indicated that LKB1 is a critical component involved in TCR signalling, and our studies provide novel insights into the mechanisms of LKB1-mediated thymocyte development.
Introduction
Positive selection of ab T cells is a process that drives the development of immature double-positive (DP) precursors into mature CD4 single positive (SP) or CD8 SP thymocytes in the thymus. Only a small proportion of DP cells expressing a functional T cell receptor (TCR) is capable of recognizing selfpeptide in the context of major histocompatibility complex (MHC), resulting in progression towards positive selection (Germain, 2002; Starr et al, 2003; Bosselut, 2004; Singer et al, 2008) . The early stages of positive selection are associated with the upregulation of TCR, CD5, and CD69 and the degree of upregulation of these respective markers is indicative of the strength of the signal received by the TCR (Bendelac et al, 1992; Swat et al, 1993; Lucas et al, 1994; Azzam et al, 1998; Starr et al, 2003) . Positive selection not only rescues shortlived DP thymocytes from programmed cell death by inducing the expression of interleukin 7 receptor (IL-7R) and the anti-apoptotic Bcl-2 protein, but also promotes their differentiation further into functionally distinct helper CD4 or cytotoxic effector CD8 T cells (Linette et al, 1994; Bhatia et al, 1995; Chao and Korsmeyer, 1998; Munitic et al, 2004) . In the later stages of positive selection, the expression of heat stable antigen (HSA; mouse CD24) on the cell surface is downregulated (Ramsdell et al, 1991) , and newly matured SP thymocytes emigrate from the thymus into peripheral lymphoid tissues (Yin et al, 2006) .
As mentioned above, thymocyte selection involves signals triggered following the engagement of the TCR with peptide-MHC complexes present on antigen-presenting cells (APC) (van Meerwijk and Germain, 1994; Hogquist and Bevan, 1996) . The formation of the immunological synapse, a supramolecular activation cluster composed of TCRs, adhesion molecules, and intracellular signalling molecules at the T cell-APC interphase, has a critical role in TCR signal transduction and T cell activation (Werlen and Palmer, 2002; Saito and Yokosuka, 2006; Prasad et al, 2009; Fooksman et al, 2010) . Following TCR stimulation, CD3 molecules are phosphorylated at immune-receptor tyrosine-based activation motifs (ITAMs) by the Src family tyrosine kinase Lck. Doubly phosphorylated ITAMs then recruit the Syk family kinase Zap70 that also becomes phosphorylated and activated. Activated Zap70 then phosphorylates the adaptor protein LAT, resulting in the formation of a multimolecular signalosome complex (LAT signalosome) consisting of various components (including phospholipase C-g 1 (PLCg1), Grb2, Itk, Vav, GADS, and SLP-76) that surround LAT (Werlen and Palmer, 2002; He et al, 2005a; Braiman et al, 2006; Seminario and Bunnell, 2008; Fu et al, 2010) . PLCg1 and other signalling molecules are then activated, leading to Ca 2 þ mobilization and activation of multiple pathways (including ERK, JNK, and p38 pathways), which eventually activate specific nuclear factors, respectively, that control thymocyte survival, differentiation, and maturation (Winslow et al, 2003; Ashwell, 2006) .
The tumour suppressor LKB1 (also known as STK11) is a serine/threonine kinase that phosphorylates and activates AMPK subfamily members in response to energy stress and the LKB1-AMPK kinase cascade has critical roles in controlling cellular polarity, proliferation, and differentiation (Bardeesy et al, 2002; Woods et al, 2003; Spicer and Ashworth, 2004; Alessi et al, 2006; Ji et al, 2007; Mirouse et al, 2007) . Recently, we and others found that LKB1 was required for thymic T cell development. Results from both laboratories showed that Lck-Cre-mediated deletion of LKB1 greatly impaired the generation of both CD4 and CD8 T cells (Tamás et al, 2010; Cao et al, 2010) . In addition to defects in b selection, the survival of DP thymocytes is greatly shortened, which may have been caused by attenuated AMPK activation and Bcl-XL expression when LKB1 was deleted (Cao et al, 2010) .
In this study, we further show that LKB1 is also involved in DP thymocyte positive selection. In the absence of LKB1, positive selection of DP cells did not proceed appropriately as evidenced by reduced surface expression of CD5, CD69, and TCR. In addition, the maturation of both CD4 and CD8 SP thymocytes was severely impaired defined by their inability to downregulate HSA expression. Intriguingly, among the proximal TCR signalling events affected was the reduction in the PLCg1 phosphorylation levels observed following TCR ligation in the absence of LKB1. We found that LKB1 was directly phosphorylated by Lck at tyrosine residues 36, 261, and 365 and that these residues were critical to TCR signal transduction. In addition, LKB1 preferentially interacted with LAT and PLCg1 following TCR engagement, whereas loss of LKB1 led to defects in the recruitment of PLCg1 to the LAT signalosome following stimulation via the TCR. In the absence of LKB1, thymocytes failed to upregulate lineage-specifying factors ThPOK and Runx3. And more, LKB1-deficient thymocytes were unable to differentiate further into CD4 and CD8 SP cells even if their survival was prolonged by ectopic expression of the anti-apoptotic Bcl-XL protein. These studies demonstrated that LKB1 is a critical TCR signalling component and taken together, these observations revealed a novel activity for LKB1 in intrathymic T cell development through the regulation of PLCg1 activation. (Cao et al, 2010) . In addition, most of these SP cells expressed high levels of an immature thymocyte marker: HSA (mouse CD24) ( Figure 1A ; Supplementary Figure S1A and B). The strong reduction in HSA low CD4 SP and CD8 SP thymocyte numbers (compared with DP thymocyte numbers; Figure 1B ) suggested that LKB1 is required for SP thymocyte maturation. The impact of LKB1 on thymocyte maturation was further confirmed by introducing the class II-restricted AND TCR transgene into LKB1-deficient mice. The frequencies of AND TCR transgenic CD4 SP cells were significantly decreased in LKB1-deficient cells ( Figure 1C ) that also failed to downregulate surface HSA expression as observed in the control mice ( Figure 1D ). Moreover, the maturation frequency of AND TCR transgenic CD4 SP cells from LKB1-deficient mice was significantly lower than those from control mice ( Figure 1E ) and AND TCR transgenic LKB1-deficient mice failed to develop normal Figure S2A and B). To further investigate the effect of LKB1 on thymocyte development, fetal thymus organ culture (FTOC) was carried out as previously described (Jones et al, 2000; Anderson and Jenkinson, 2007) . As shown in Figure 1F , the CD4 SP population was greatly reduced in AND TCR transgenic mice when LKB1 was ablated.
Results

LKB1 deficiency impairs
Thymocytes fail to undergo normal positive selection in the absence of LKB1 Positive selection of DP thymocytes results from the ligation of MHC-peptide/TCR complexes followed by the upregulation of TCR, CD5, and CD69 (Bendelac et al, 1992; Swat et al, 1993; Lucas et al, 1994; Azzam et al, 1998) . Intriguingly, LKB1-deficient mice had significantly fewer TCR high , CD5 high , and CD69
high DP thymocytes ( Figure 2A ) similar to LKB1-deficient AND TCR transgenic mice ( Figure 2B ) when compared with littermate controls, respectively. Importantly, the transitional TCR high CD4 þ CD8 low cells, which include progenitors of both the CD4 and CD8 lineages, did not fully upregulate surface CD69 expression in the absence of LKB1 ( Figure 2C ). Correlatively, AND TCR transgenic Va11 high
CD4
þ CD8 low cells from LKB1-deficient mice failed to express CD5 at a level as that on their controls ( Figure 2D Figure 2E and F), suggesting that LKB1 was required for them to avoid death by neglect. Taken together, both the initiation and progression of positive selection were severely impacted in the absence of LKB1.
To further investigate the role of LKB1 in the development of DP thymocytes to SP cells, LKB1 fl/fl mice containing the LoxP-flanked gene encoding LKB1 were bred with mice expressing Cre recombinase under the control of the Cd4 promoter (Cd4Cre) to generate Cd4Cre þ LKB1 fl/fl mice. As expected, attenuated expression of LKB1 mRNA was found at the DP stage but not at the double-negative (DN) stage in Figure S3B) . Analysis of thymocyte cellularity revealed that the absolute cell numbers of either DP, CD4 þ CD8 low , CD4 SP, or CD8 SP (but not DN cells) were significantly decreased when LKB1 was deleted particularly at the DP stage (Supplementary Figure S3C) . The loss of DP thymocytes may be caused by enhanced apoptosis in Cd4Cre þ LKB1 fl/fl mice (Supplementary Figure S3D) , which is consistent with our previous observation that LKB1 was required for the survival of DP thymocytes (Cao et al, 2010) . Importantly, neither CD4 SP nor CD8 SP cells from Cd4Cre þ LKB1 fl/fl mice were observed to have surface HSA downregulation (Supplementary Figure S3E) . Moreover, Cd4Cre þ LKB1 fl/fl mice had lower maturation frequencies of CD4 SP and CD8 SP thymocytes than control animals (Supplementary Figure S3F ) and failed to generate normal peripheral CD4 and CD8 T cell populations (Supplementary Figure S3G and Figure S3J and K), indicating that LKB1 is involved in thymocyte positive selection.
Loss of LKB1 impairs PLCc1 phosphorylation and calcium flux
The lack of CD5 high and CD69 high thymocytes in LckCre þ LKB1 fl/fl mice provided a hint that LKB1-deficient thymocytes might not be able to receive either appropriate signalling or sufficiently strong signals via their TCRs. To assess the influence of LKB1 on TCR signalling, DP thymocytes were stimulated in vitro with immobilized either anti-CD3 or anti-CD3 and anti-CD2 antibodies as described (Cibotti et al, 1997) . TCR stimulated wild-type DP thymocytes presented with significantly upregulated CD5 and CD69 levels compared with LKB1-deficient cells that did not upregulate either CD5 or CD69 ( Figure 3A) .
To investigate the role of LKB1 in TCR signal transduction in greater detail, the activation of several critical downstream targets affected by TCR-mediated signalling was screened following TCR stimulation. We first examined whether transient activation components associated with the TCR signal initiation machinery were altered. These results showed that similar phosphorylation levels of Src family kinases and Zap70 were present independent of LKB1 ( Figure 3B ; Supplementary Figure S4 ). Further analysis revealed that loss of LKB1 weakened TCR-induced PLCg1 phosphorylation, but not phosphorylation of the LAT adaptor ( Figure 3B ; Supplementary Figure S4 ). Intracellular staining further confirmed that LKB1 was required for complete PLCg1 fl/fl mice or littermate controls were unstimulated or stimulated with plate-bound anti-CD3 (5 mg/ml) or anti-CD3 (5 mg/ml) and anti-CD2 (5 mg/ml) antibodies for 16 h. After collection, cells were stained with surface markers in combination with propidium iodide and gated live cells (over 30%) were analysed for CD5 and CD69 expression. Numbers above the brackets indicate the percentage of CD5 high or CD69 high cells. (B) Sorted DP thymocytes from LckCre þ LKB1 fl/fl mice or littermate controls were labelled with biotinylated anti-TCR (10 mg/ml) and anti-CD4 (10 mg/ml) and were then cross-linked with streptavidin for the indicated times or left untreated (0 min). Total lysates from these cells were subjected to SDS-PAGE and analysed with antibodies against the tyrosine phosphorylation form of Src, Zap70, LAT, or PLCg1, respectively. Expression of total PLCg1 served as a loading control. (C) Sorted DP thymocytes from LckCre þ LKB1 fl/fl mice or littermate controls were stimulated as described above and then analysed for intracellular PLCg1 phosphorylation. (D) Thymocytes harvested from LckCre þ LKB1 fl/fl mice or littermate controls were loaded with Fluo-3 and surface stained with anti-CD8, biotinylated anti-TCR, and anti-CD4. After cross-linked with streptavidin (top) or stimulated with ionomycin (bottom), gated CD8 positive thymocytes were analysed for Ca 2 þ mobilization. Arrows indicate the time points when streptavidin or ionomycin were added. Results are representative of three (A-C) or four (D) independent experiments. Figure 3C ). Consistent with the attenuated tyrosine phosphorylation of PLCg1, the TCR-induced calcium flux was also markedly reduced in LKB1-deficient DP thymocytes compared with DP thymocytes from wild-type mice. The differences were no longer observed when these two thymocyte populations were treated with ionomycin (a calcium ionophore that directly induces intracellular calcium ion mobilization) ( Figure 3D ). Therefore, loss of LKB1 specifically disrupted PLCg1 activation and calcium signalling. Correlatively, the expression levels of CD5 were identical between LKB1-deficient and control thymocytes following stimulation with PMA and ionomycin (data not shown).
LKB1 is a substrate for the tyrosine kinase Lck
The above observations suggested that LKB1 was a downstream target associated with TCR signalling and, in fact, LKB1 was tyrosine phosphorylated in DP thymocytes following TCR stimulation ( Figure 4A ). Since it has been shown that the Src family tyrosine kinase Fyn could phosphorylate LKB1 in adipose tissues (Yamada et al, 2010) , we examined whether LKB1 could serve as a downstream target of Lck, the main Src family kinase associated with the TCR signalling pathway. As shown in Supplementary Figure S5 and Figure 4A , LKB1 tyrosine phosphorylation was upregulated following TCR stimulation and this upregulation was markedly diminished in the presence of a widely used Lck-specific inhibitor (Burchat et al, 2000; Treanor et al, 2006) . Interestingly, either overexpressed or endogenous LKB1 associated with Lck ( Figure 4B and C) . Moreover, the constitutive active form of Lck (Lck Y505F), but not the wild-type Lck, was able to phosphorylate LKB1 on tyrosine residues ( Figure 4D ). In vitro phosphorylation assays further revealed that Lck Y505F directly phosphorylated LKB1 ( Figure 4E ), demonstrating that LKB1 served as a substrate for the Lck tyrosine kinase and that it was an essential early component associated with TCR signalling.
Lck phosphorylates LKB1 at tyrosine residues 36, 261, and 365 Given that Fyn phosphorylates LKB1 on tyrosine residues 261 and 365 (Yamada et al, 2010) , we first tried to verify whether these two sites were also phosphorylation sites for Lck. Mutation of either tyrosine 261 or tyrosine 365 attenuated LKB1 phosphorylation levels, suggesting that both were Lck phosphorylation sites ( Figure 5A ). However, LKB1 phosphorylation was still detected when these two sites were both mutated ( Figure 5A ), indicating that other candidate phosphorylation sites on LKB1 still existed. Mass spectrometric analysis used to detect LKB1 phosphorylation sites was then performed, and the N-terminal tyrosine 36 was identified as a novel phosphorylation site ( Figure 5B ; Supplementary Figure S6) . A single mutation of tyrosine 36 reduced LKB1 phosphorylation levels, further confirming that tyrosine 36 served as a target for Lck-mediated phosphorylation ( Figure 5C ). Notably, tyrosine 36 did not seem to be a phosphorylation site for Fyn (Supplementary Figure S7) . Only the triple mutant but not any double mutant combinations consisting of tyrosines 36, 261, and 365 abolished LKB1 tyrosine phosphorylation ( Figure 5C ). These data suggested that LKB1 tyrosine residues 36, 261, and 365 represented the major tyrosine phosphorylation sites for Lck kinase. Importantly, all the single mutants and the double mutants attenuated LKB1 tyrosine phosphorylation following TCR stimulation ( Figure 5D ). The dramatic decrease in tyrosine phosphorylation of the triple mutant suggested that these residues represented bona fide phosphorylation sites of LKB1 in response to TCR ligation ( Figure 5D ).
Before examining the role of these tyrosine sites in the activation of PLCg1, an in vitro electroporation transfection assay was set up for rescue analysis. As shown in Figure 5E , ectopic expression of GFP-tagged LKB1 (LKB1-GFP) enhanced PLCg1 phosphorylation in wild-type DP thymocytes following TCR stimulation. Importantly, overexpression of LKB1-GFP but not of GFP efficiently improved PLCg1 phosphorylation in LKB1-deficient DP thymocytes. The mutant forms of LKB1 were then used for rescue analysis. Both the single mutant (Y36F, LKB1M1-GFP) and the double mutant (Y261/365F, LKB1M2-GFP) partially rescued PLCg1 phosphorylation in LKB1-deficient thymocytes following TCR stimulation, but neither mutant fully restored PLCg1 phosphorylation compared with wild-type LKB1. PLCg1 phosphorylation in the triple mutant (Y36/261/365/F, LKB1M3-GFP) could not be detected ( Figure 5F ). Taken together, these results demonstrated that these three LKB1 tyrosine residues are indispensable for PLCg1 activation.
LKB1 promotes PLCc1 recruitment to the LAT signalosome
Tyrosine phosphorylation of PLCg1 is mediated by Itk within the LAT signalosome following TCR stimulation (Min et al, 2009) . Considering that LKB1 is a bona fide serine/threonine kinase (but not a tyrosine kinase), it is unlikely that LKB1 directly phosphorylates PLCg1 or its upstream kinases. For this reason, we speculated that the impact of LKB1 on PLCg1 phosphorylation was to promote the recruitment of PLCg1 to the LAT signalosome as a scaffold protein. As shown in Figure 6A , LKB1 predominately associated with LAT and colocalized with LAT only after the TCR was engaged ( Figure 6B ). Further co-immunoprecipitation analysis showed that PLCg1 associated with LKB1 and that this association increased with prolonged TCR stimulation ( Figure 6C ). Importantly, TCR-induced association of LAT with PLCg1, but not with Grb2 or SLP-76, was significantly decreased in the absence of LKB1 ( Figure 6D ). And the recruitment of PLCg1 to the LAT signalosome was impaired in the absence of LKB1 ( Figure 6E) . Intriguingly, the association between LKB1 and PLCg1 positively correlated with the phosphorylation status of the LKB1 tyrosine residues 36, 261, and 365. The amount of co-immunoprecipitated PLCg1 was highest when wild-type LKB1 was used, intermediate when LKB1M1 or LKB1M2 were used and lowest in the presence of LKB1M3 ( Figure 6F ). Together, these observations suggested that TCR engagement leads to the recruitment of LKB1 to the LAT signalosome that in turn enhances the recruitment of PLCg1 to LAT. 
LKB1-deficient thymocytes fail to upregulate lineagespecifying factors
Given that thymocyte positive selection is promoted by TCRinduced gene transcription (Collins et al, 2009 ) and LKB1-deficient mice failed to generate mature CD4 SP and CD8 SP thymocytes, we finally asked whether LKB1 deletion affects the upregulation of CD4/CD8 lineage-specifying factors, such as ThPOK (which mediates the development of DP thymocytes to the CD4 lineage) (Sun et al, 2005; He et al, 2005b) and Runx3 (which is important for CD8 lineage differentiation) (Sato et al, 2005; Collins et al, 2009) . As shown in Figure 7A , the transitional CD4 þ CD8 low cells failed to retain the expression of ThPOK and Runx3 in the absence of LKB1. Sorted CD69 low/À DP thymocytes were stimulated with anti-CD3 and anti-CD2 antibodies at various time intervals and real-time RT-PCR analysis was then performed to characterize the transcription status of the above factors. Wild-type thymocytes substantially upregulated the mRNA levels of both ThPOK and Runx3. In contrast, LKB1-deficient thymocytes failed to initiate such a transcriptional programme ( Figure 7B ). These observations indicated that the triggering of lineage-specific gene transcription depends on LKB1-mediated TCR signals. We thus speculated that LKB1-deficient thymocytes may still be unable to differentiate to the SP stage even if their impaired survival was rescued. To this end, FTOC experiments were performed. The viability of LKB1-deficient thymocytes was enhanced by ectopic expression of the anti-apoptotic Bcl-XL protein ( Figure 7C) ; however, these cells could not differentiate further into CD4 SP and CD8 SP cells ( Figure 7D ). 
Discussion
The serine/threonine kinase LKB1 primarily acts as an upstream kinase that phosphorylates threonine residue 172 of the energy sensor AMPK, resulting in an inhibition of cellular energy expenditure, thereby regulating cell survival, growth, differentiation, and proliferation (Woods et al, 2003; Shaw et al, 2004; Alessi et al, 2006; Han et al, 2006; Ji et al, 2007) . Similarly, we found that LKB1 controlled the survival of DP thymocytes by regulating AMPK activation and Bcl-XL expression (Cao et al, 2010) . Here, we report that by regulating the activation of PLCg1, LKB1 also controlled thymocyte positive selection. After LKB1 was phosphorylated by the Src family tyrosine kinase Lck at tyrosine residues 36, 261, and 365, activated LKB1 promoted the recruitment of PLCg1 into the LAT signalosome, thereby regulating TCR signalling and thymocyte positive selection.
LKB1 has been reported to be phosphorylated at several serine (Ser 31, Ser 325, Ser 431, and Ser 404) or threonine (Thr 185, Thr 189, Thr 336, and Thr 366) residues by kinases such as PKA, RSK, or ATM or in some circumstances via autophosphorylation (Sapkota et al, 2001 (Sapkota et al, , 2002 Alessi et al, 2006) . A recent study showed that an Src family tyrosine kinase (Fyn) regulated energy expenditure by phosphorylating LKB1 at tyrosine residues 261 and 365 in adipose tissues, thereby accommodating energy demands via AMPK regulation (Yamada et al, 2010) . In this study, we unexpectedly found that the Lck kinase phosphorylated LKB1 at tyrosine residues 36, 261, and 365 and that all of these tyrosine residues were required for optimal TCR signal transduction since mutation of any one of these residues (into phenylalanine) failed to fully activate PLCg1 following TCR stimulation. Notably, this kind of post-translational modification on LKB1 occurred in response to an external signal, an observation never before reported.
An interesting feature revealed in the present study was that LKB1 had a non-redundant role in the activation of PLCg1. LKB1 deficiency led to markedly reduced tyrosine phosphorylation of PLCg1 following TCR stimulation, and consequently, calcium ion mobilization was greatly impaired. However, it is unlikely that LKB1 directly phosphorylated PLCg1 at Tyr residues and PLCg1 was unlikely to serve as a substrate for LKB1 (Alessi et al, 2006; Mirouse et al, 2007) . It has been reported that PLCg1 was activated in a two-step manner (Veri et al, 2001) . That is, PLCg1 was first recruited to the LAT signalosome and then phosphorylated by upstream kinases. Moreover, unlike other cells where LKB1 is primarily localized to the nucleus (Smith et al, 1999; Alessi et al, 2006; Yamada et al, 2010) , LKB1 localized to the cytoplasm of thymocytes (data not shown). These strongly supported the possibility that LKB1 may serve as a scaffold protein facilitating the recruitment of PLCg1. In fact, TCR stimulation enhanced the interaction of LKB1 with both PLCg1 and LAT, and LKB1 deficiency impacted the enhanced recruitment of PLCg1 to the LAT signalosome. These observations suggested that LKB1 was a critical component associated with TCR signalling pathways. Taken together, we concluded that following TCR stimulation, activated Lck phosphorylated low/À DP thymocytes were left unstimulated (0 h) or stimulated with plate-bound anti-CD3 (2 mg/ml) and anti-CD2 (2 mg/ml) antibodies for indicated time points. Real-time RT-PCR was used to compare the relative mRNA expression of lineage-specifying genes. The percentage of live cells from both LKB1-deficient and wild-type thymocytes was over 87% (4 h), 85% (6 h), and 78% (8 h LKB1 at tyrosine residues 36, 261, and 365, thereby promoting the recruitment of PLCg1 to the LAT signalosome facilitating efficient phosphorylation of PLCg1 by Itk, an upstream PLCg1 kinase that also localized within the LAT signalosome.
Given that LKB1 is required for PLCg1 activation and TCR signal transduction, it is understandable why LKB1-deficient DP thymocytes failed to further differentiate into mature CD4 SP and CD8 SP thymocytes, although other possibilities cannot be excluded, for example metabolic defect of SP thymocytes in the absence of LKB1. LKB1-deficient thymocytes not only failed to fully upregulate TCR-induced transcription of CD5 and CD69 surface molecules, they were also unable to upregulate lineage-specifying factors upon TCR stimulation. One may speculate that the impaired generation of mature SP thymocytes could be the result of decreased thymocyte survival since LKB1/AMPK signalling controls Bcl-XL expression. Interestingly, LKB1-deficient thymocytes were still unable to differentiate further into CD4 and CD8 SP cells even if their survival was restored by ectopic expression of Bcl-XL protein. Thus, it is possible that the failure in the generation of SP cells in LKB1-deficient mice was, at least partially, due to impaired PLCg1 activation, which is consistent with a recent report that PLCg1 is required for thymocyte maturation (Fu et al, 2010) . Notably, defects in PLCg1 activation could also be an important reason why b selection was also impaired following LKB1 deletion as observed by us and others (Cao et al, 2010; Tamás et al, 2010) . Taken together, LKB1 appeared to execute multiple functions during thymic T cell development by activating distinct pathways that (1) regulated thymocyte survival via LKB1/AMPK signalling pathways (Cao et al, 2010) and (2) controlled thymocyte positive selection via LKB1/PLCg1/calcium signalling pathways.
Considering the high energy demand associated with TCR activation (Fox et al, 2005) , it is probably beneficial to the efficacy of the immune responses that TCR signal transduction pathways lead to the activation of AMPK prior to ATP depletion. Intriguingly, Lck-mediated LKB1 phosphorylation at tyrosine residues 36, 261, and 365 may fulfil this requirement since tyrosine phosphorylation of these three residues efficiently resulted in TCR signal transduction by recruiting PLCg1, and meanwhile, phosphorylation of tyrosine residues 261 and 365 led to regulation of AMPK activation (Yamada et al, 2010) , resulting in a repression of energy-consuming processes and simultaneously enhancing energy-generating processes. Therefore, LKB1 is critical for T lineage cells not only to avoid cell death from energy-or nutrient-related stress, but also to avoid death by energy exhaust following continuous or high intensity TCR engagement.
Materials and methods
Mice C57BL/6 and AND TCR transgenic mice were maintained in the Shanghai Laboratory Animal Center (Chinese Academy of Sciences). The Lkb1 floxed alleles, the LckCre, and the Cd4Cre mouse strains have been described previously (Bardeesy et al, 2002; Pan et al, 2002; Dong et al, 2008) . LckCre or Cd4Cre mice were crossed with LKB1 fl/fl mice to generate LckCre þ LKB1 fl/fl or Cd4Cre þ LKB1 fl/fl mice. Mice aged 4-8 weeks were used for further analysis. All mice were maintained in a specific pathogen-free (SPF) facility and were genotyped by PCR analysis of genomic DNA. All animal experiments were in compliance with National Institutes of Health Guidelines and were approved by the institutional animal care and use committee of the Shanghai Institutes for Biological Sciences (Chinese Academy of Sciences).
Antibodies and reagents
The following monoclonal antibodies used for cell staining and sorting were purchased from BD PharMingen (San Jose, CA): anti-CD4 (GK1.5 and RM4-4), anti-CD8a (53-6.7), anti-TCRb (H57-597), anti-TCR Va11 (RR8-1), anti-CD5 (53-7.3), anti-CD69 (H1.2F3), anti-CD2 (RM2-5), anti-CD3 (145-2C11), anti-HSA (M1/69), anti-IL-7R (SB/199), and anti-Bcl-2 (3F11). Anti-phospho-Zap70 (Y319), anti-LKB1 (M-18, for immunoprecipitation), anti-PLCg1 (E-12, for immunofluorescence microscopy), and Lck inhibitor (7-cyclopentyl-5-(4-phenoxyphenyl)-7H-pyrrolo [2,3-d] pyrimidin-4-ylamine, sc-204052) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-phospho-PLCg1 (Y783), anti-PLCg1, anti-phosphoSrc (Y319), anti-Grb2, anti-SLP-76, anti-LKB1 (27D10, for immunoblot analysis), and anti-phospho-tyrosine (P-Tyr-100) were purchased from Cell Signaling Technology (Danvers, MA). Anti-phospho-LAT (Y136) was from Abcam (Cambridge, UK). Anti-human CD3 (UCHT1) and anti-human CD28 (CD28.2) were from Biolegend (San Diego, CA).
Cell preparation, staining, and purification Single-cell thymocyte or lymphocyte suspensions were prepared and surface stained as described (Wang et al, 2008) . Cell fluorescence was acquired using a two-laser FACSCalibur (BD Biosciences) flowcytometer and data were analysed with FlowJo software (TreeStar, Inc., Olten, Switzerland). Intracellular staining was carried out as described previously (Liu et al, 2003) . Thymocyte subsets were purified by magnetic depletion (Miltenyi Biotec, Bergisch Gladbach, Germany) or by an FACSAria II (BD Biosciences). Cell purity assessed by surface staining and flow cytometry was over 90%.
Cell culture and transfection
The human 293T cell line (American Type Culture Collection, Manassas, VA) was maintained in complete DMEM (Invitrogen, Carlsbad, CA) and transfected by calcium phosphate precipitation. Thymocytes were electroporated as previously described (Bell et al, 2001; Cao et al, 2010) . Thymocytes (1 Â10 7 ) suspended in 250 ml RPMI 1640 medium mixed with plasmids encoding for GFP, GFP-LKB1, or GFP-LKB1 mutants, respectively, were electroporated using a square wave electroporator (Gene pulser Xcell, Bio-Rad Laboratories, Hercules, CA) using the following settings: pulse length ¼ 20 ms, pulses ¼ 1 and 4 mm, Gap cuvettes and a voltage ¼ 360 V. After culture for 8 h, cells were harvested and used for additional analysis. Jurkat cells were electroporated at 250 V and 950 mF.
Thymocyte stimulation TCR cross-linking was carried out as previously described (Liu et al, 2003) . Briefly, thymocytes were stained with anti-CD4 (RM4-4) and anti-CD8 for FACS sorting. Freshly isolated DP cells were resuspended in RPMI 1640 medium supplemented with 1 mM Na 3 VO 4 (Sigma, St Louis, MO) and surface stained with biotinylated anti-TCR (10 mg/ml) and anti-CD4 (10 mg/ml, GK1.5) on ice for 15 min. Cells were cross-linked with 20 mg/ml streptavidin (Sigma) at various time intervals at 371C. Samples were subjected to further analysis including TCR stimulation through plate-bound antibodies as described previously by coating tissue culture plates with anti-CD3 or with anti-CD3 and anti-CD2 with indicated concentration in phosphate-buffered saline (PBS) at 41C overnight (Cibotti et al, 1997) . Prepared cells were resuspended at a concentration of 5 Â10 5 /ml in complete RPMI 1640 medium and added to respective wells. Stimulations were performed in a cell culture incubator at 371C under 5% CO 2 . PMA (10 ng/ml) þ ionomycin (500 ng/ml) stimulation was carried out as previously described.
Calcium flux assay
The calcium flux assay was done as previously described (Liu et al, 2003) . Thymocytes were preloaded with Fluo-3 AM (Molecular Probes, Invitrogen) for 30 min at 371C in the dark and then stained with anti-CD8, biotinylated anti-TCR (10 mg/ml), and anti-CD4 (10 mg/ml) antibodies. Cells were washed and resuspended in HBSS, 2% fetal calf serum (FCS). After the cells were warmed to 371C, baseline Ca 2 þ levels were measured for 2 min at quiescence. After addition of streptavidin (5 mg/ml), Ca 2 þ mobility was measured by Fluo-3 AM fluorescence for 10 min. An FACSAria II was used for data collection. Real-time RT-PCR RNA was extracted and quantified as described (Wang et al, 2008 
Immunoprecipitation and immunoblot analysis
For immunoprecipitation, cells were lysed in Triton X-100 lysis buffer (10 mM Tris-HCl, pH 7.4, 150, or 400 mM NaCl, 50 mM NaF, 1 mM EDTA, 10% glycerol, 1% Triton X-100, 2 mM Na orthovanadate, and protease inhibitor cocktail). Supernatants were incubated with the indicated antibodies and then immunoprecipitated using protein A/G sepharose beads (Santa Cruz Biotechnology). Samples were subjected to immunoblot analysis with indicated antibodies.
In vitro phosphorylation assay
In vitro phosphorylation assays were carried out as previously described (Yamada et al, 2010) . His-tagged Lck-Y505F mutant and the LKB1 fusion protein were purified, respectively, using Ni-NTA agarose beads (Qiagen, Valencia, CA). His-LKB1 protein (1 mg) and His-Lck-Y505F mutant (1 mg) were incubated in the presence of an Src Mg/ATP cocktail for 1 h at 351C. Samples were separated on a 10% sodium dodecyl sulphate polyacrylamide gels (SDS-PAGE) and immunobloting was performed with the indicated antibodies as previously described (Wang et al, 2008) .
Immunofluorescence microscopy
Immunofluorescence analysis was carried out as previously described (Park et al, 2009) . Briefly, sorted CD4 SP thymocytes or Dynabead-purified primary T cells were incubated with Dynabeads (Invitrogen) coated with anti-CD3 at a ratio of 1:1. After the incubation, T cell-conjugated Dynabeads were plated on poly-Llysine-coated coverslips for 20 min at 371C. Cells were then fixed with 4% (wt/vol) paraformaldehyde for 15 min at 251C and permeabilized with permeabilization buffer (0.1% (vol/vol) Triton X-100 and 5% (vol/vol) FCS in PBS, pH 7.5) for 10 min at 251C. Cells were incubated with anti-LAT and anti-LKB1 (M-18) or antiPLCg1 (E-12) at 41C overnight and then incubated with donkey or goat secondary antibodies conjugated to Alexa Fluor 488 or Cy3, respectively, under similar conditions. Slides were mounted with
